Genflow Biosciences (LON:GENF) (OTCQB:GENFF)

Genflow Biosciences (LON:GENF) (OTCQB:GENFF) is a pioneering biotechnology research company dedicated to discovering and advancing novel therapeutics that aim to halt or slow the aging process, promoting healthier lives for both humans and dogs. With a focus on innovative solutions, Genflow Biosciences is committed to extending healthspan and improving the quality of life through cutting-edge research and development.

Located at BioPark Gosselies rue Auguste Piccard 48, Gosselies, 6041, BE, Genflow Biosciences is driven by a mission to deliver therapeutics that address the underlying mechanisms of aging. The company's lead compound leverages a centenarian variant of the SIRT6 gene, demonstrating promising preclinical results. This novel approach positions Genflow Biosciences at the forefront of the longevity biotechnology field.

Genflow Biosciences (LON:GENF) (OTCQB:GENFF) is committed to pushing the boundaries of biotechnology. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work and connect with potential partners and investors.